• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA SIMPLIFEYE INSERTER; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB ENVISTA SIMPLIFEYE INSERTER; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number 21987_B10
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/19/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The device was discarded and not returned for evaluation.Investigation of this event is in progress.A follow-up report will be submitted upon completion of investigation.
 
Event or Problem Description
It was reported that during implantation of an intraocular lens (iol) into the right eye, the surgeon noticed an approximately 4mm crack in the lens optic starting near the optic/haptic junction and extending towards the center of the lens.The iol was removed from the eye and a successful intraoperative lens exchange was performed using a backup iol of the same model and diopter.A suture was placed across the main incision to close the wound.In the surgeon's opinion, the most likely cause of event is the defective lens.Patient prognosis is stable.
 
Additional Manufacturer Narrative
Additional info: g3, h2, h6, h11.A review of the device history record (dhr) did not find any non-conformities or anomalies related to the reported event.The trend analysis, risk analysis, and directions for use are considered acceptable with the product performing within anticipated rates.Corrective measures have been identified to mitigate future similar occurrences.Bausch & lomb will continue to monitor similar events to determine if additional actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENVISTA SIMPLIFEYE INSERTER
Common Device Name
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
Manufacturer (Section G)
MEDICEL AG
dornierstrasse 11
altenrheim CH-94 23
SZ   CH-9423
Manufacturer Contact
shayan habibi
21 north park place blvd.
clearwater, FL 33759
7277246600
MDR Report Key21112885
Report Number0001313525-2025-00003
Device Sequence Number8760197
Product Code MSS
UDI-Device Identifier00757770547449
UDI-Public(01)00757770547449(17)270131(10)2315B6
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K192005
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/10/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number21987_B10
Device Lot Number2315B6
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/10/2024
Supplement Date Received by Manufacturer01/09/2025
Initial Report FDA Received Date01/09/2025
Supplement Report FDA Received Date02/07/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured08/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ENVISTA INTRAOCULAR LENS
Outcome Attributed to Adverse Event Required Intervention;
Patient Age49 YR
Patient SexUnknown
-
-